Reduced binding of [18F]altanserin to serotonin type 2A receptors in aging: Persistence of effect after partial volume correction

Brain Research

Volumn 813, Issue 1, 1998, Pages 167-171

  Meltzer, Carolyn Cidis ^a   Smith, Gwenn ^a   Price, Julie C ^a   Reynolds III, Charles F ^a   Mathis, Chester A ^a,b   Greer, Phil ^a   Lopresti, Brian ^a   Mintun, Mark A ^a   Pollock, Bruce G ^a   Ben Eliezer, Doron ^a   Cantwell, Michael N ^a   Kaye, Walter ^a   Dekosky, Steven T ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Aging; Emission tomography; Partial volume correction; Serotonin receptor

Indexed keywords

ALTANSERIN; FLUORINE 18; SEROTONIN; SEROTONIN 2A RECEPTOR; DIAGNOSTIC AGENT; DRUG DERIVATIVE; FLUORINE; KETANSERIN; SEROTONIN RECEPTOR;

ADULT; AGED; AGING; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CONTROLLED STUDY; DEPRESSION; DRUG RECEPTOR BINDING; FEMALE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; ADOLESCENT; BRAIN; METABOLISM; MIDDLE AGED; PATHOLOGY; RADIOASSAY;

ADOLESCENT; ADULT; AGED; AGING; BRAIN; FEMALE; FLUORINE RADIOISOTOPES; HUMANS; KETANSERIN; MALE; MIDDLE AGED; RADIOLIGAND ASSAY; RECEPTORS, SEROTONIN;

EID: 0032582908     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00909-3     Document Type: Article

References (26)

1. Arranz B., Eriksson A., Mellerup E., Plenge P., Marcusson J. Effect of aging in human cortical pre- and postsynaptic serotonin binding sites. Brain Res. 620:1993;163-166.
2. Biver F., Lotstra F., Monclus M., Wikler D., Damhaut P., Mendlewicz J., Goldman S. Sex difference in 5HT2 receptors in the living human brain. Neurosci. Lett. 204:1996;25-28.
3. Blin J., Baron J.C., Dubois B., Crouzel C., Fiorelli M., Attar-Levy D., Pillon B., Fournier D., Vidailhet M., Agid Y. Loss of brain 5HT2 receptors in Alzheimer's disease. Brain. 116:1993;497-510.
4. 2 receptor binding sites in depressed suicide victims. Brain Res. 443:1988;272-280.
5. S. DeKosky, A. Palmer, Neurochemistry of aging, in: M. Albert, J. Knoefel (Eds.), Clinical Neurology of Aging, Oxford Press, New York, 1994, pp. 79-101.
6. Gonzales G., Carillo C. Blood serotonin levels in postmenopausal women: effects of age and serum oestradiol levels. Maturitas. 17:1993;23-29.
7. 3H ]ketanserin binding in the human brain postmortem: effect of suicide Brain Res. 507:1990;208-215.
8. Iyo M., Yamasaki T. The detection of age-related decrease of dopamine D1, D2 and serotonin 5-HT2 receptors in living human brain. Prog. Neuro-Psychopharmacology Biol. Psychiatr. 17:1993;415-421.
9. Jakab R., Goldman-Rakic P. 5-Hydroxytryptamine 2A-serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites. Proc. Natl. Acad. Sci. U.S.A. 95:1998;735-740.
10. Lemaire C., Cantineau R., Guillaume M., Plenevaux A., Christiaens L. Fluorine-18 altanserin: a radioligand for the study of serotonin receptors with PET: radiolabeling and in vivo biologic behavior in rats. J. Nucl. Med. 32(12):1991;2266-2272.
11. 11C-methyl ]-(-)cocaine PET studies in human subjects J. Cereb. Blood Flow Metab. 10:1990;7407.
12. I. Lucki, The spectrum of behaviors influenced by serotonin, Biol. Psychiatry (1988) in press.
13. Marcusson J., Morgan D., Winblad B., Finch C. Serotonin-2 binding sites in human frontal cortex and hippocampus. Selective loss of S-2A sites with age. Brain Res. 311(11):1984;51-56.
14. Mason N., Huang Y., Holt D., Perevuznik J., Lopresti B., Mathis C. Synthesis and characterization of [F-18]4-(4-fluoro-benzoyl)piperidine, an [F-18]altanserin metabolite. J. Nucl. Med. 38:1997;56P.
15. Meltzer C.C., Leal J.P., Mayberg H.S., Wagner H.J., Frost J.J. Correction of PET data for partial volume effects in human cerebral cortex by MR imaging. J. Comput. Assist. Tomogr. 14:1990;561-570.
16. Morilak D., Garlow S., Ciaranello R. Immunocytochemical localization and description of neurons expressing serotonin-2 receptors in the rat brain. Neuroscience. 54:1993;701-717.
17. Pazos A., Probst A., Palacios J.M. Serotonin receptors in the human brain: IV. Autoradiographic mapping of serotonin-2 receptors. Neuroscience. 21:1987;123-139.
18. Robson L., Gower A., Kendall D., Marsden C. Age-related behavioural, neurochemical and radioligand binding changes in the central 5-HT system of Sprague-Dawley rats. Psychopharmacology. 113:1993;274-281.
19. 18F ] and positron emission tomographic imaging Psychiatr. Res. 68:1996;11-22.
20. 18F ]altanserin: results in young normal controls J. Cereb. Blood Flow Metab. 15:1995;787-797.
21. 11C ]-raclopride in normal human subjects Am. J. Psychiatry. 154:1997;490-496.
22. Sparks D. Aging and Alzheimer's Disease. Altered cortical serotonergic binding. Arch. Neurol. 46:1989;138-140.
23. Tanna N.K., Kohn M.I., Horwich D.N., Jolles P.R., Zimmerman R.A., Alves W.M., Alavi A. Analysis of brain and cerebrospinal fluid volumes with MR imaging: impact on PET data correction for atrophy: Part II. Aging and Alzheimer dementia. Radiology. 178:1991;123-130.
24. Wiernsperger N. Serotonin 5-HT2 receptors and brain circulation. J. Cardiovasc. Pharmacol. 16:1990;S20-S24.
25. Wong D., Wagner H.J., Dannals R., Links J., Frost J., Ravert H., Wilson A., Rosenbaum A., Gjedde A., Douglass K., Petronis J., Folstein M., Toung J., Burns H., Kuhar M. Effects of age on dopamine and serotonin receptors measured by positron tomography in the living human brain. Science. 226:1984;1393-1396.
26. Woods R.P., Mazziotta J.C., Cherry S.R. MRI-PET registration with automated algorithm. J. Comput. Assist. Tomogr. 17:1993;536-546.